ABEO (Abeona Therapeutics Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by ABEO officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-01 | Mark Alvino | Director | Sell | — | — |
| 2026-07-22 | Joseph Walter Vazzano | Chief Financial Officer | Sell | — | — |
| 2026-07-09 | Joseph Walter Vazzano | Chief Financial Officer | Sell | — | — |
| 2026-07-09 | Brendan M. O'Malley | SVP, Chief Legal Officer | Sell | — | — |
| 2026-07-09 | Madhav Vasanthavada | Chief Commercial Officer | Sell | — | — |
| 2026-07-09 | Vishwas Seshadri | Chief Executive Officer | Sell | — | — |
| 2026-07-02 | Leila Alland | Director | Sell | — | — |
| 2026-06-17 | Madhav Vasanthavada | Chief Commercial Officer | J | — | — |
| 2026-06-15 | Christine Berni Silverstein | Director | Sell | — | — |
| 2026-06-09 | Brendan M. O'Malley | SVP, Chief Legal Officer | Sell | — | — |
| 2026-06-09 | Vishwas Seshadri | Chief Executive Officer | Sell | — | — |
| 2026-06-09 | Joseph Walter Vazzano | Chief Financial Officer | Sell | — | — |
| 2026-06-09 | Madhav Vasanthavada | Chief Commercial Officer | Sell | — | — |
| 2026-05-26 | Mark Alvino | Director | G | — | — |
| 2026-05-22 | Mark Alvino | Director | Sell | — | — |
| 2026-05-15 | Eric Crombez | Director | Sell | — | — |
| 2026-05-11 | Madhav Vasanthavada | Chief Commercial Officer | Sell | — | — |
| 2026-04-07 | Keith A. Goldan | Director | A | — | — |
| 2026-03-16 | Joseph Walter Vazzano | Chief Financial Officer | Sell | — | — |
| 2026-02-04 | Christine Berni Silverstein | Director | Sell | — | — |
| 2026-02-02 | Eric Crombez | Director | Sell | — | — |
| 2026-02-02 | Mark Alvino | Director | Sell | — | — |
| 2026-02-02 | Donald A. Wuchterl | Director | Sell | — | — |
| 2026-02-02 | Leila Alland | Director | Sell | — | — |
| 2026-01-27 | Donald A. Wuchterl | Director | A | — | — |
| 2026-01-27 | Michael Amoroso | Director | A | — | — |
| 2026-01-27 | Mark Alvino | Director | A | — | — |
| 2026-01-27 | Eric Crombez | Director | A | — | — |
| 2026-01-27 | Bernhardt G Zeiher | Director | A | — | — |
| 2026-01-27 | Leila Alland | Director | A | — | — |
| 2026-01-27 | Christine Berni Silverstein | Director | A | — | — |
| 2026-01-27 | Faith L. Charles | Director | A | — | — |
| 2026-01-26 | Madhav Vasanthavada | Chief Commercial Officer | MIXED | — | — |
| 2026-01-22 | Joseph Walter Vazzano | Chief Financial Officer | Sell | — | — |
| 2026-01-22 | Brendan M. O'Malley | SVP, Chief Legal Officer | Sell | — | — |
| 2026-01-22 | Vishwas Seshadri | Chief Executive Officer | Sell | — | — |
| 2026-01-21 | Mark Alvino | Director | Sell | — | — |
| 2026-01-20 | Brendan M. O'Malley | SVP, Chief Legal Officer | A | — | — |
| 2026-01-20 | Joseph Walter Vazzano | Chief Financial Officer | A | — | — |
| 2026-01-20 | Vishwas Seshadri | Chief Executive Officer | A | — | — |
| 2025-12-29 | Vishwas Seshadri | Chief Executive Officer | Sell | — | — |
| 2025-11-14 | Mark Alvino | Director | Sell | — | — |
| 2025-10-16 | Vishwas Seshadri | Chief Executive Officer | Sell | — | — |
| 2025-10-01 | Brendan M. O'Malley | SVP, Chief Legal Officer | Sell | — | — |
| 2025-10-01 | Joseph Walter Vazzano | Chief Financial Officer | Sell | — | — |
| 2025-10-01 | Vishwas Seshadri | Chief Executive Officer | Sell | — | — |
| 2025-09-22 | Brendan M. O'Malley | SVP, Chief Legal Officer | Sell | — | — |
| 2025-08-15 | Eric Crombez | Director | Sell | — | — |
| 2025-08-15 | Joseph Walter Vazzano | Chief Financial Officer | Sell | — | — |
| 2025-07-22 | Joseph Walter Vazzano | Chief Financial Officer | Sell | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Chief Executive Officer | 1,306,108 | — |
| — | Chief Financial Officer | 492,079 | — |
| — | Director | 467,716 | — |
| — | Director | 443,172 | — |
| — | SVP, Chief Legal Officer | 427,953 | — |
| — | Chief Commercial Officer | 290,623 | — |
| — | Director | 217,779 | — |
| — | Director | 176,407 | — |
| — | Director | 167,935 | — |
| — | Director | 162,614 | — |
| — | Director | 119,562 | — |
| — | Director | 84,458 | — |
| — | Director | 62,065 | — |
| — | Director | 37,313 | — |
| — | Director | 32,751 | — |
| — | Director | 16,907 | — |
| — | Director | 16,907 | — |
| — | Chief Financial Officer | 16,007 | — |
| — | Director | 11,519 | — |
| — | Chief Executive Officer | 4,000 | — |
| — | Director | 3,899 | — |
| — | Director | 1,518 | — |
| — | Director | 1,438 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ABEO quote page; the site-wide leaderboard is on the insider transactions hub.